Outcome of adalimumab monotherapy in paediatric non-infectious uveitis

Overview of attention for article published in Pediatric Rheumatology, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 7 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 33,844 followers.

Continuation of adalimumab monotherapy is an effective therapeutic option for the treatment of non-infectious uveitis in children who are intolerant to the combination of adalimumab and methotrexate or mycophenolate mofetil.

09 Mar 2023

Reply Repost Favourite

RT @LuzEConcha: 📖👓Tratamiento con adalimumab en uveítis no infecciosa en niños que fueron intolerantes a metotrexate o micofenolato 📖👓 #uv…

09 Mar 2023

Reply Repost Favourite

RT @LuzEConcha: 📖👓Tratamiento con adalimumab en uveítis no infecciosa en niños que fueron intolerantes a metotrexate o micofenolato 📖👓 #uv…

09 Mar 2023

Reply Repost Favourite

RT @LuzEConcha: 📖👓Tratamiento con adalimumab en uveítis no infecciosa en niños que fueron intolerantes a metotrexate o micofenolato 📖👓 #uv…

07 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.